(Q28206616)

1

0 references

T Wieder

2

0 references

I Sturm

3

0 references

K Schulze-Osthoff

Apoptosis signaling by death receptors.

4

0 references

language of work or name

English

0 references

publication date

July 2001

0 references

published in

Leukemia

0 references

volume

15

0 references

page(s)

1022-32

0 references

issue

7

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Autoimmune lymphoproliferative syndrome, a disorder of apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

The molecular basis for apoptotic defects in patients with CD95 (Fas/Apo-1) mutations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Correction of autoimmune lymphoproliferative syndrome by bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

The dilemma of apoptosis in myelodysplasia and leukemia: a new promise of therapeutic intervention?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Apoptosis in patients with myelodysplastic syndromes: differential involvement of marrow cells in 'good' versus 'poor' prognosis patients and correlation with apoptosis-related genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Apoptotic cell death induced by a mouse-human anti-APO-1 chimeric antibody leads to tumor regression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Lethal effect of the anti-Fas antibody in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Safety and antitumor activity of recombinant soluble Apo2 ligand

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Regulation of apoptosis in the immune system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

CD95's deadly mission in the immune system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Apoptosis by death factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Tumor necrosis factor receptor and Fas signaling mechanisms.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

A death-domain-containing receptor that mediates apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-kappa B

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Identification and functional characterization of DR6, a novel death domain-containing TNF receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signalling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

An antagonist decoy receptor and a death domain-containing receptor for TRAIL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

The receptor for the cytotoxic ligand TRAIL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Characterization of two receptors for TRAIL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

A novel receptor for Apo2L/TRAIL contains a truncated death domain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

TRANCE-RANK, a new signal pathway involved in lymphocyte development and T cell activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Bone resorption by osteoclasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Unraveling function in the TNF ligand and receptor families

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Identification and characterization of a new member of the TNF family that induces apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

NMR structure and mutagenesis of the Fas (APO-1/CD95) death domain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death--inducing signaling complex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Human ICE/CED-3 protease nomenclature

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

TRAIL receptor-2 signals apoptosis through FADD and caspase-8

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

RAIDD is a new 'death' adaptor molecule

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Defects in regulation of apoptosis in caspase-2-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Daxx, a novel Fas-binding protein that activates JNK and apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Human Daxx regulates Fas-induced apoptosis from nuclear PML oncogenic domains (PODs).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Fas ligand-induced c-Jun kinase activation in lymphoid cells requires extensive receptor aggregation but is independent of DAXX, and Fas-mediated cell death does not involve DAXX, RIP, or RAIDD.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

The Bcl-2 protein family: arbiters of cell survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Dissecting the pathways to death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Bcl-2 proteins: regulators of apoptosis or of mitochondrial homeostasis?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Loss of function of cytochrome c in Jurkat cells undergoing fas-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

The most unkindest cut of all: on the multiple roles of mammalian caspases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Crystal structure of the cysteine protease interleukin-1 beta-converting enzyme: a (p20/p10)2 homodimer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

The three-dimensional structure of apopain/CPP32, a key mediator of apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Death by a thousand cuts: an ever increasing list of caspase substrates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Bcl-2 antagonizes apoptotic cell death induced by two new ceramide analogues.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Caspase-independent cell killing by Fas-associated protein with death domain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Cell death beyond apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Two distinct pathways leading to nuclear apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Molecular characterization of mitochondrial apoptosis-inducing factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Death receptors: signaling and modulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Mitochondria and apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Mitochondrial control of cell death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Activation of caspase-8 in drug-induced apoptosis of B-lymphoid cells is independent of CD95/Fas receptor-ligand interaction and occurs downstream of caspase-3.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Caspase-8/FLICE functions as an executioner caspase in anticancer drug-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Cleavage of BID during cytotoxic drug and UV radiation-induced apoptosis occurs downstream of the point of Bcl-2 action and is catalysed by caspase-3: a potential feedback loop for amplification of apoptosis-associated mitochondrial cytochrome c rel

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Induction of apoptosis in human hematopoietic U937 cells by granulocyte-macrophage colony-stimulating factor: possible existence of caspase 3-like pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Suppression of TNF-alpha-induced apoptosis by NF-kappaB

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

A1 functions at the mitochondria to delay endothelial apoptosis in response to tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

A phase II trial of recombinant tumor necrosis factor in patients with advanced colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Reduction of liver Fas expression by an antisense oligonucleotide protects mice from fulminant hepatitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Activation and activation-induced death of human tonsillar B cells and Burkitt lymphoma cells: lack of CD95 (Fas/APO-1) ligand expression and function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

CD95/Fas-triggered apoptosis of activated T lymphocytes is prevented by dendritic cells through a CD58-dependent mechanism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Fas ligand—cought between scylla and charybdis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Steering anti-cancer drugs away from the TRAIL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Human brain-cell death induced by tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

TRAIL is a potent inducer of apoptosis in myeloma cells derived from multiple myeloma patients and is not cytotoxic to hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Clonal variability in CD95 expression is the major determinant in Fas-medicated, but not chemotherapy-medicated apoptosis in the RPMI 8226 multiple myeloma cell line

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Resistance to CD95-mediated apoptosis through constitutive c-FLIP expression in a non-Hodgkin's lymphoma B cell line.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Malignant and reactive cells from human lymphomas frequently express Fas ligand but display a different sensitivity to Fas-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Relapse in childhood acute lymphoblastic leukemia is associated with a decrease of the Bax/Bcl-2 ratio and loss of spontaneous caspase-3 processing in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Structural and biochemical basis of apoptotic activation by Smac/DIABLO

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Molecular determinants of the caspase-promoting activity of Smac/DIABLO and its role in the death receptor pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Effect of recombinant tumor necrosis factor on HL-60 cells: cell-cycle specificity and synergism with actinomycin D.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Modulation of cisplatin sensitivity and growth rate of an ovarian carcinoma cell line by bombesin and tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Sensitization of cancer cells treated with cytotoxic drugs to fas-mediated cytotoxicity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Chemotherapeutic drugs sensitize pre-B ALL cells for CD95- and cytotoxic T-lymphocyte-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Induction of the TRAIL receptor KILLER/DR5 in p53-dependent apoptosis but not growth arrest

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

The TRAIL decoy receptor TRUNDD (DcR2, TRAIL-R4) is induced by adenovirus-p53 overexpression and can delay TRAIL-, p53-, and KILLER/DR5-dependent colon cancer apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Death and decoy receptors and p53-mediated apoptosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Concurrent disruption of p16INK4a and the ARF-p53 pathway predicts poor prognosis in aggressive non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Incidence and prognostic significance of MDM2 oncoprotein overexpression in relapsed childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Sensitivity to Fas-mediated apoptosis in pediatric acute lymphoblastic leukemia is associated with a mutant p53 phenotype and absence of Bcl-2 expression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Positive and negative regulation of apoptotic pathways by cytotoxic agents in hematological malignancies.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Differential role of caspase-8 and BID activation during radiation- and CD95-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Ionizing radiation and chemotherapeutic drugs induce apoptosis in lymphocytes in the absence of Fas or FADD/MORT1 signaling. Implications for cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

2-Chloro-2'-deoxyadenosine induces apoptosis through the Fas/Fas ligand pathway in human leukemia cell line MOLT-4.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402169

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2402169

1 reference

Consolidated OpenCitations Corpus – April 2017

Dimensions Publication ID

1613080

1008826234

0 references

1613080

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference